HDAC6-IN-16 is a quinazolinone-based HDAC6 inhibitor with anticancer properties. It suppresses cancer cell proliferation by inhibiting colony formation, inducing G2/M cell cycle arrest, and promoting apoptosis in vitro, making it a useful tool for oncology and epigenetics research.
Molekulargewicht:
417.48
Formel:
C23H19N3O3S
Target-Kategorie:
HDAC,Apoptosis
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
